Probiotics for Next Generations 2.0

Dear Colleagues,

This publication marks the continuation of our 2020 Special Issue, entitled "Probiotics for Next Generations".

https://www.mdpi.com/journal/microorganisms/special_issues/next_generations_probiotics

Classically, the science of microbiology has focused its efforts in the in-depth study of pathogenic microorganisms that pose a health hazard to humankind or animals. However, advances in microbiology and in the disciplines that support it—such as immunology, molecular biology, and genomics—have allowed researchers to discover and study a group of microorganisms that are key actors in the maintenance of the health and wellbeing of humans and animals. Multidisciplinary in-depth research has provided the scientific basis for the use of these beneficial microbes for the prevention of infections, in combating cancer development, or in the treatment of inflammatory diseases. Most of the beneficial microorganisms currently studied and used to promote health belong to the genera Lactobacillus and Bifidobacterium, and were isolated mainly from dairy products or intestinal microbiota. However, in recent years, new potentially beneficial microbes have begun to emerge owing to our better understanding of the composition and function of human and animal microbiota and the re-evaluation of autochthonous food and feed sources found exclusively in some regions of the world. In this sense, new strains of Lactobacillus and Bifidobacterium coming from unique environments, in addition to microorganisms of other genera isolated from the dominant members of the microbiota from different mucosal and non-mucosal tissues, have recently emerged as beneficial microbe candidates. These microorganisms, with new or improved functional and biotechnological properties, have potential applications for the development of probiotic products for the coming generations.

We invite you to submit original research papers to this Special Issue, entitled “Probiotics for Next Generations 2.0”. This issue will address the isolation of potential new beneficial microorganisms from autochthonous food sources or from members of mucosal and non-mucosal tissues from humans and animals, the study of their functional and biotechnological properties, and the evaluation of their cellular and molecular interactions with the host.

Prof. Dr. Haruki Kitazawa
Dr. Julio Villena
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• probiotics
• microbiota
• autochthonous foods and feeds
• beneficial microbes